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Abstract
Perlecan/HSPG2, a large, monomeric heparan sulfate proteoglycan (HSPG), is a key component 
of the lacunar canalicular system (LCS) of cortical bone, where it is part of the mechanosensing 
pericellular matrix (PCM) surrounding the osteocytic processes and serves as a tethering element 
that connects the osteocyte cell body to the bone matrix. Within the pericellular space surrounding 
the osteocyte cell body, perlecan can experience physiological fluid flow drag force and in that 
capacity function as a sensor to relay external stimuli to the osteocyte cell membrane. We 
previously showed a reduction in perlecan secretion alters the PCM fiber composition and 
interferes with bone’s response to mechanical loading in vivo. To test our hypothesis that perlecan 
core protein can sustain tensile forces without unfolding under physiological loading conditions, 
atomic force microscopy (AFM) was used to capture images of perlecan monomers at nanoscale 
resolution and to perform single molecule force measurement (SMFMs). We found that the core 
protein of purified full-length human perlecan is of suitable size to span the pericellular space of 
the LCS, with a measured end-to-end length of 170 ± 20 nm and a diameter of 2–4 nm. Force 
pulling revealed a strong protein core that can withstand over 100 pN of tension well over the drag 
forces that are estimated to be exerted on the individual osteocyte tethers. Data fitting with an 
extensible worm-like chain model showed that the perlecan protein core has a mean elastic 
constant of 890 pN and a corresponding Young’s modulus of 71 MPa. We conclude perlecan has 
physical properties that would allow it to act as a strong but elastic tether in the LCS.
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1. Introduction
The basement membrane (BM) protein perlecan [1], also known as heparan sulfate 
proteoglycan 2 (HSPG2), is one of the largest (470–700kDa) and oldest (>550 million years) 
matrix molecules with many important functions [2,3]. One of the ancient key functions of 
perlecan is to maintain the integrity of functional borders separating tissues and tissue layers 
through its long (~200 nm) [4] and five modular core protein domains that interact with 
various matrix molecules [2]. Perlecan’s modular structure (as shown in Fig. 1) has been 
retained throughout millions of years of evolution [2,5], and the largest portion of perlecan, 
domain IV, is about 90% identical across mammalian species [2]. The perlecan gene, 
HSPG2, can be found in early simple metazoan organisms with few cell layers and in 
developing and adult tissue borders in mammals as well. These tissue borders represent 
functional barriers such as those between extracellular matrix (ECM) and blood (e.g., 
glomerular basement membrane (BM)) [6], among muscle fibers [7], and at the 
osteochondral junctions of long bones [8]. Perlecan contributes to the structural stability of 
BM by binding to and linking together the individual laminin and collagen networks [9], 
which is critical for kidney’s filtration function. Although initially identified as a structural 
component in BM, regulatory functions of perlecan have been recognized through the 
interactions of its attached heparan sulfate glycosaminoglycan (GAG) side chains with 
growth factors and other matrix proteins [4]. This newly gained evolutionary function for 
perlecan is especially prominent in tissues that typically experience mechanical loading, 
such as muscle, cartilage and bone tissue. In skeletal muscle tissue, perlecan maintains fast 
muscle mass and fiber composition in response to overloading [10]. In perlecan deficient 
slow-twitch soleus muscles, unloading resulted in loss of muscle mass through autophagy by 
the mTORC1 pathway [11]. Recent studies demonstrated that the perlecan-rich pericellular 
matrix (PCM) surrounding chondrocytes in articular cartilage exhibits distinct mechanical 
properties from the territorial ECM and modulates chondrocytes responses to mechanical 
stimuli via binding and release of FGF-2 [12–14]. More recently, our group identified the 
presence of perlecan in another functional interface, i.e., osteocyte lacunar-canalicular 
system (LCS) and its involvement in osteocyte-mediated mechanosensing in response to 
load-induced fluid flow [15,16].
Interstitial fluid flow in the bone LCS functions as a major mechanical stimulus that drives 
various cellular processes during bone adaptation [17]. Being the most abundant bone cells 
and strategically positioned in the middle of mineralized matrix, osteocytes serve as the 
primary sensors to perceive external mechanical signals through interstitial fluid flow 
[18,19]. For the past two decades, advances from in vitro and in vivo studies have elucidated 
multiple mechanotransduction pathways (e.g., Wnt/SOST and OPG/RANKL) for osteocytes 
to regulate the functions of osteoblasts and osteoclasts and thus orchestrate bone’s response 
to mechanical stimuli (see recent reviews [20–22]). However, the mechanosensing apparatus 
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that allows osteocyte to detect interstitial fluid remained unclear. Although a fibrous PCM 
containing proteoglycans and transverse tethers were hypothesized to surround the 
osteocytes in the bone LCS by Weinbaum and coworkers in [18,23], respectively, the 
chemical composition of the PCM and the tethering candidates were not identified until ten 
years later. In 2011, we confirmed perlecan to be an important component of the osteocyte 
PCM, where reduced expression of perlecan results in fewer tethering elements within the 
pericellular space and narrower canalicular channels [15]. Furthermore, we demonstrated a 
30% reduction of the PCM fiber density and the lack of anabolic responses to in vivo 
mechanical loading using a perlecan deficient mouse [16]. Based on these in vivo results and 
the known properties of perlecan, we hypothesized that the perlecan-containing PCM tethers 
serve as flow sensors in the bone LCS and the fluid drag forces experienced by the PCM 
tethers were predicted to be at piconewton levels under physiological loading conditions 
[16]. The question remains as to whether perlecan molecule can withstand the predicted 
fluid drag forces in the bone LCS.
Although recognized as a key structural component of many territorial and pericellular 
matrices, perlecan’s mechanical properties have yet to be explored. Given perlecan’s linear 
modular structure, we considered it an ideal candidate for single molecule force 
measurements (SMFMs) using atomic force microscopy (AFM). This method has been 
widely adopted to study the mechanical strengths of individual proteins, ligand-receptor 
interactions, and large protein complexes [24]. Selective examples include investigations of 
mechanical properties of proteins involved in cytoskeleton rearrangement [25–28], tissue 
elasticity and ECM integrity [29,30]. In particular, SMFM by AFM has been very useful in 
elucidating the mechanical behaviors of large modular proteins containing tandem repeating 
motifs including a long stretch of contiguous immunoglobulin (Ig) modules such as titin 
[25,26,31]. The ability of titin to resist stretching and/or bending under mechanical force 
was demonstrated using SMFMs [32,33]. Perlecan contains Ig repeats in domain IV Fig. 1, 
similar to titin, but the abilities of perlecan to provide mechanical stability and flexibility to 
perlecan-rich tissues and their borders have not been measured.
Our work here sought to investigate perlecan’s mechanical properties to understand how 
perlecan might serve as an osteocyte PCM mechanosensing tether that endures physiological 
fluid flow drag within the bone LCS. We hypothesized that the perlecan core protein 
sustains tensile forces without unfolding under physiological loading conditions. For these 
studies, we carried out AFM imaging and force measurements on purified full-length 
perlecan with and without its GAG sidechains. While perlecan was engaged with the AFM 
tip and the tip was moved away under a controlled fashion, we recorded the tensile force 
experienced by perlecan as a function of extension length. The force-extension curves were 
fit with a worm-like chain model to determine perlecan’s mechanical properties. Our 
objective was to demonstrate that the physical properties of perlecan are consistent with its 
proposed mechanosensing role in the bone LCS.
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2. Results
2.1. Perlecan morphology by AFM imaging
Purified perlecan was isolated from the conditioned media of HT29 cells, a human colon 
carcinoma cell line, following previously established protocols [34] (Fig. 2 A). AFM images 
showed single isolated perlecan monomer structures (Fig. 2 B). Although protein aggregates 
were observed on occasion, single monomers were clearly visible. The core protein 
contained globular features having diameters of 2–4 nm and heights of 5–10 nm.
Single linear molecules were measured from end-to-end to determine a contour length (Fig. 
3 A). The perlecan contour was converted to digitized coordinates to obtain accurate 
measurements (Fig. 3 B). A distribution of perlecan contours revealed a most common 
extension of ~170 ± 20 nm in length (Fig. 3 C). Persistence length was determined by 
plotting the cosine correlation function against the contour separation (Fig. 3 D). A high 
correlation (~1) exists when two different coordinates have tangent vectors with similar 
angles, as one would expect in a straight or rigid molecule. On the other hand, when the 
tangents are pointing in opposite directions, as occurs in a curved region (Fig. 3 B), the 
correlation is lower (< 1). The plot in Fig. 3 D shows that the cosine correlation for perlecan 
decreases the further away two points are from one another. Overall, perlecan molecules 
favored a long thin flexible conformation with a Lp = 19 nm ± 5 nm (Eq. 1). Image analysis 
was attributed to the perlecan core itself, because GAGs were not consistently visible under 
the conditions used to optimally image core protein structures.
2.2. Perlecan Elastic Properties by AFM Pulling
The AFM pulling scheme we used is depicted in Fig. 4 A. While perlecan molecules 
remained attached to the gold substrate, randomly chosen segments of the molecule, which 
could be either core protein or GAG, were located then pulled upon using the AFM tip and 
extended until the sample detached from the cantilever. The resulting force-extension curves 
of the full-length native perlecan showed a single detachment peak with no noticeable 
unfolding events (see Fig. 4 B) regardless of where the tip attached to the proteoglycan. For 
SMFMs, force curves follow a similar trace pattern, where the last peak represents the 
rupture of the tip-sample interaction. This detachment peak is distinguished from peaks that 
represent unfolding processes, in that after the sample-tip interaction is lost the tip snaps 
back to its starting neutral position and thus the force returns to baseline levels. We fit the 
force-extension curves to the eWLC model, which predicts perlecan is extended beyond its 
resting contour length, given the relative high forces (~150 pN, Fig. 4).
The most probable values, resulting from Gaussian fits to histogram distributions, are Lp = 
1.2 nm, and K = 2000 pN (Fig. 5 A and B). To examine the core protein exclusively and 
ensure the measurements were not associated with the GAG portion of the proteoglycan, we 
completely removed the GAGs by digesting perlecan with heparitinase I, II, III and 
chondroitinase ABC and repeated the pulling analysis. We found that the profile of the force 
curves resembled what we saw in full-length perlecan, displaying a single detachment. 
When we fit the data to the eWLC model, we observed the core protein of perlecan to have 
Lp = 22 nm and K = 890 pN (Fig. 5 C and D). The Lp = 22 nm of the perlecan core from 
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pulling is consistent with the Lp = 19 nm obtained from imaging. However, full-length 
perlecan had a Lp = 1.2, much lower than that of the core.
In the experiments above, no module unfolding with the characteristic sequence of multiple 
peaks was observed, perhaps due to the presence of intradomain disulfide bonds. To confirm 
this, we added DTT to break the disulfide bonds of perlecan, to enable the force-induced 
unfolding. When 1 mM DTT was added, the force-extension curves exhibited sequences of 
sawtooth pattern, characteristic of the sequential unfolding of the protein modules [25,35,36] 
(see Fig. 6 A). The force curves were fitted with an inextensible WLC model (Eq. 3). Fig. 6 
B shows that from the Gaussian fits to the histogram, the unfolding force with the highest 
occurrence frequency was 110 pN. The histogram of the change in contour length ΔLc, has a 
peak at 35 nm (Fig. 6 C). The observed unfolding forces of disulfide-cleaved perlecan are 
within the range of forces required to unfold elastic behaving proteins [25,35,36]. Under 
normal circumstances, perlecan exists as a stable intact protein, and only when chemically 
denatured by oxidizing the disulfides did perlecan unfold under tensile mechanical stress.
3. Discussion
Our AFM data revealed that perlecan has a long and strong core protein that resists 
conformational changes when under mechanical distress. This result supports our previous 
hypothesis that perlecan possesses the physical properties to serve as a transverse tether in 
the LCS to sense fluid drag caused by mechanical loading [16]. We measured the unstressed 
end-to-end length of the perlecan core protein (~170 nm) to demonstrate that perlecan was 
of sufficient size to transverse the annular gap (~100 nm) and tether the osteocyte cell body 
to the canalicular wall [37]. In addition, we demonstrated the mechanical strength of 
perlecan core protein through single molecule pulling. Compared to the stretch modulus of 
the elastic protein titin [38], the stretch modulus K of perlecan core protein was found to be 
almost 5 times greater (890 pN). Assuming the perlecan core protein as a rod with a cross-
sectional area A (diameter of 4nm, Fig. 2), the tensile modulus of the core protein E= K/A = 
71 MPa, which are smaller than those of collagen I fibril (< 5 GPa, [39]) and actin filaments 
(1.8 GPa, [40]) but much larger than that of focal adhesion (5.5 kPa, [41]).
For perlecan to function as a viable osteocyte cell tether, it must be able to traverse the 
pericellular space and endure fluid flow drag forces. AFM images were taken to obtain an 
accurate measure of the true length native purified monomeric perlecan. Previously 
measurements of various aspects of perlecan’s dimensions and molecular topography have 
been reported, including one study finding the core to be around 80 nm in length and each 
GAG attachment to extend up to 170 nm [42]. In another study, AFM imaging was used to 
characterize the size of perlecan, revealing two molecular volumes of the protein core at 290 
nm3 and 710 nm3 [43]. Our results differ from previous studies, possibly due to the 
difference in the source perlecan and isolation method. We found on average, measured by 
AFM images, that perlecan extended about 170 nm in length (Fig. 2), agreeing with our past 
prediction based upon composite of detailed rotary shadowing electron microscopy and 
AFM images of recombinant domains [4]. Variations can be attributed to perlecan’s flexible 
nature and ability to fold onto itself in variety of ways. In addition, it must be considered 
that adsorbed proteins can undertake substrate-induced conformations. Despite these 
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uncertainties, our measurements of “resting” linear dimensions lead us to conclude that a 
single perlecan monomer easily can span the entire pericellular space, which has been 
measured to be about 100 nm wide, from osteocyte cell body to the mineralized bone 
surface [44].
To determine if perlecan is strong enough to handle mechanical loading, we estimated the 
fluid drag forces under normal loading conditions (400 microstrain in mouse tibia) to be 
18.4 pN over one micron length of cell process [16]. This translates to less than 1 pN of drag 
force acting transversely on each tether and less than 10 pN tension along the long axis of 
the core protein, assuming the tether anchors at the bone wall and cell membrane at an angle 
larger than 2.8 degree to the radial direction of the canaliculus. This anchoring angle can be 
easily achieved if the effective length of the tether is no shorter than 100.04 nm to span the 
100 nm gap between the cell membrane and the wall (Fig. 7). Our data suggest that perlecan 
is strong enough to sustain the tensional forces under physiological loading conditions (~10 
pN for 400 microstrain loading), given its much higher rupture forces (~150 pN, Fig. 4) 
under AFM pulling. The high end of physiology strain is about 2000 microstrain, resulting 5 
times of the fluid drag, which is still lower than the rupture force measured for the perlecan 
core protein. In the pulling experiments, it was impossible to control the exact locations that 
the perlecan monomer anchored to the AFM tip and the substrate. Thus, the final rupture 
might occur at either end of the contact regions or along perlecan’s linear structure including 
protein core and GAG side chain. However, unfolding or rupturing the protein core was 
highly unlikely under the testing condition. We did not observe the sequential peaks that are 
characteristic of protein unfolding and we only observed single peaks as the full-length 
perlecan was pulled (Fig. 4). Protein core unfolding could be observed after treatment with 
DTT to break the disulfide bonds (Fig. 6). Even under this denatured condition, the mean 
force to unfold perlecan was at the level of 110 pN and the final rupture forces could be as 
high as more than 500 pN (see the last peaks in Fig. 6 A). These data led us to conclude that 
the perlecan protein core can easily sustain tensions at the order of 10 pN under 
physiological loading conditions of the bone LCS.
As a potential mechanosensing tether, we must compare the strength of perlecan itself to 
those of the anchors that it forms with the osteocyte cell membrane and bone matrix. One 
possibility is that perlecan interacts with the mineralized bone via its GAG side chains of 
domain I. The bone matrix is rich in collagen I, which is involved in heparin binding. It has 
been shown that both soluble and cell surface heparan sulfate proteoglycans bind with high 
affinity to native interstitial collagen I fibrils, with Kds approximately 10−10 M and 10−9 M, 
respectively [45,46]. Our lab has previously shown that perlecan domain I can bind directly 
to collagen I monomers and fibrils, via its heparan sulfate side chains [47]. The cleavage of 
perlecan’s domain I GAG chains with heparinases, but not chondroitinase, completely 
prevented binding to collagen I (PMID 15738663). Single molecule approaches have been 
used to measure the binding strength of heparan sulfate, with one study finding that as high 
as 310 pN was required to rupture a multivalent heparan sulfate-ligand interaction [48]. This 
high strength of GAG-ligand interaction may explain our observations that perlecan with 
GAG showed a shorter persistent length Lp (1.2 nm vs. 22 nm) and a higher stretch elasticity 
K (2000 vs. 890 pN) than perlecan devoid of GAG (Fig. 5). It has been shown that perlecan 
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links together the laminin and collagen IV rich networks of the epidermal BM in a spot-
weld-like manner [49]. Perlecan’s heparan sulfate chains are integrated into collagen 
network, which is likely how perlecan interacts with the mineralized bone wall of the LCS. 
Separating these two perlecan-linked independent networks requires repeated application of 
mechanical force. Unfortunately, the total amount of force required to break the perlecan 
linkage was not determined. In any case, the forces required to separate the bound protein-
protein and protein-carbohydrate pairs (190–400 pN) [50–52] tend to be well above the 
forces exerted by fluid drag in the LCS (10 pN). If indeed domain I is the attachment point 
to bone surface, it is most likely the opposing C-terminal end of perlecan (domains IV-V) is 
anchored to the osteocyte cell surface. Domain V interacts with cells surface integrins, most 
notably β1 integrin [53]. Interestingly, β1 integrin was shown to be involved in bone 
mechanotransduction, whereupon the knockout of β1 integrin in cortical osteocytes limited 
bone loss resulting from disuse [54]. Domain IV also serves as a likely link for cell 
attachment, considering its length (nearly half of the perlecan) and its multiple repeats of Ig 
motifs (Fig. 1), which are often recognized in cell adhesion processes [55]. It is also possible 
that the perlecan tether may be indirectly linked to the osteocyte surface through a PCM-cell 
membrane complex. Despite the lack of mechanical measurements of the anchors at the two 
ends of the PCM tether, perlecan’s ability to bind and link together various ECM proteins 
supports further investigations of the possible tether configurations in the bone LCS.
There are several limitations for our study. In many AFM single molecule studies, small 
recombinant proteins are often used with a priori known unfolding peak patterns. With 
perlecan, the force-extension profile was unknown, raising the concern whether or not our 
AFM pulling scheme was capable of detecting or causing any unfolding events. We thus 
destabilized the disulfide bonds of perlecan, making it more vulnerable to force-induce 
unfolding (Fig. 6). This set of experiments increased our confidence that the lack of multiple 
peaks during pulling perlecan and perlecan core protein indicates that there was no protein 
unfolding under the testing condition. Another limitation was that we were unable to control 
the exact probe attachment points during the pulling experiments. Ideally, we would have 
the most terminal ends of the protein attached to substrate and AFM tip. This would allow us 
to capture the stretch profile of the entire molecule. Functionalized substrate and AFM tip 
may help to achieve this idealized testing configuration.
In this study, AFM was used to capture images of perlecan monomers at nanoscale 
resolution and to perform single molecule force measurements. We found that the core 
protein of purified full-length human perlecan is of suitable size to span the pericellular 
space of the LCS, with a measured end-to-end length of 170 ± 20 nm and a diameter of 2–
4nm. Force pulling revealed a strong protein core that can withstand over 100 pN of tension, 
well over the drag forces that are estimated to be exerted on the individual osteocyte tethers. 
Data fitting with an extensible worm-like chain model showed that the perlecan protein core 
has a mean elastic constant of 890 pN and a corresponding Young’s modulus of 71 MPa. 
We conclude perlecan has the physical properties that would allow it to act as a strong but 
elastic tether in the LCS.
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4. Experimental Procedures
4.1. Perlecan purification from HT-29 conditioned media
HT-29, a human colon carcinoma cell line, formerly called WiDR, was chosen because 
these cells produce perlecan as their primary HSPG [56,57]. Cells were purchased from the 
American Type Culture Collection (Cat. No. CCL-218, ATCC, Manassas, VA) and cultured 
as described previously [56,58]. When cells were nearly 100% confluent as judged by eye in 
Corning Hyperflasks, they were switched to 2% (v/v) fetal bovine serum (FBS) medium, 
and medium was collected and processed with protease inhibitors as recently described [58]. 
The solutions were processed through a S34100 Amicon spiral wound 100 kDa molecular 
weight cutoff media concentrator cartridge. The resulting high molecular weight 
concentrated solution was subjected to diethyl aminoethyl (DEAE) anion exchange 
chromatography (GE Healthcare, Pittsburgh, PA). Equilibration buffer contained 2 M urea, 
50 mM PIPES (pH 7.0), 250 mM NaCl, 2.5 mM EDTA, 0.5 mM benzamadine, 0.5 mM 
phenylmethyl sulfonylfluoride (PMSF), and 0.02% (w/v) sodium azide. Elution buffer was 
identical to equilibration buffer except the NaCl was 750 mM. Eluted 1.5 mL fractions were 
collected and the absorbance at 280 nm read. Fractions were individually analyzed by dot 
blot immunoassay with anti-perlecan Dm IV antibody A7LC (described below). Pooled 
fractions containing perlecan were dialyzed in MilliQ water and centrifuged in a speed vac 
until the desired concentration was obtained. The resulting perlecan enriched solution was 
separated by Sepharose CL-4B (Sigma-Aldrich, St. Louis, MO) gel filtration 
chromatography in the presence of 0.8 M NaCl phosphate buffered saline (PBS, pH 7.4) 
buffer. Perlecan peak containing fractions were pooled dialyzed in MilliQ water and 
centrifuged in a speed vac. Perlecan pools were subjected to gradient heparin Sepharose 6 
fast flow (GE Healthcare) chromatography in PBS containing 0.2, 0.3, 0.5, 1.0, and 1.5 M 
NaCl. Perlecan, as determined by A7LC dot blot, eluted at 0.3 M NaCl. Perlecan was 
centrifuged in a speed vac and dialyzed in a final PBS buffer. Samples were aliquotted and 
stored at −80°C. Purity was assessed by silver stain as described below.
4.2. Cleavage of glycosaminoglycan (GAG) side chains
To investigate the elastic properties of the core protein exclusively, perlecan’s GAG side 
chains were cleaved by incubating the molecule with heparitinase I, II, III and 
chondroitinase ABC in PBS with 2 mM calcium chloride at 0.1 units per enzyme at 37°C 
overnight. Enzymes were separated from the core protein by passing samples through an 
anti-perlecan A74 antibody (a generous gift from John M. Whitelock) affinity column 
following established protocols (26). All final perlecan containing fractions were pooled, 
dialyzed in MilliQ water and centrifuged in a speed vac. The A7L6C (Sigma-Aldrich) 
antibody was used for all dot-blot and western blot analyses. Purity and removal of GAG 
chains was confirmed by collapse seen via silver stain. Heparan sulfate from bovine kidney 
was purchased from Sigma-Aldrich and used as a control for AFM pulling.
4.3. Dot blot and silver stain conditions
Purified full-length and GAG digested perlecan were denatured at 99°C with reducing 
sample buffer (final 60 mM Tris-HCl, 1% (w/v) SDS, 10% glycerol, 2% (v/v) 2-
mercaptoethanol, pH 6.8 with tracking dye) for 5–10 min. Samples were separated with 
Wijeratne et al. Page 8
Matrix Biol. Author manuscript; available in PMC 2017 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
SDS-polyacrylamide gel electrophoresis (PAGE) in 1 mm Novex NuPAGE 4–12% 
acrylamide gradient Bis-Tris buffered gels (Invitrogen, Carlsbad, CA) in a Novex NuPAGE 
system (Invitrogen) with 1 × MOPS SDS buffer (Invitrogen) at 150 constant volts for 
approximately 80 min. SeeBlue® Plus2 molecular weight marker (Invitrogen) was used to 
determine molecular weight. Silverstains were performed with the Silverquest Silver Stain 
kit according to manufacturer's directions (Invitrogen). For perlecan dot blots, 20 µL of 
sample was added to a Bio-Rad slot blot apparatus (Cat. No. 170-6545) and allowed to bind 
pre-PBS rinsed 0.45 µm nitrocellulose membrane for 2 h at room temperature. After vacuum 
suction, the dot blot was blocked in a 3% (w/v) BSA Tris buffered saline with 0.05% (v/v) 
Tween-20 (TBST) for 2 h at room temperature. A7LC antibody (Invitrogen) at 1:5,000 was 
incubated in the blocking solution overnight on a 4°C shaker. After 3 by 5 min TBST 
washes, the membranes were incubated with 1:200,000 goat anti-rat HRP conjugated 
antibody in 3% BSA TBST for 2 h at room temperature. Blots were washed again and 
incubated with chemiluminescence substrate (West Dura Extended Substrate, Pierce, 
Rockford, IL) for 5 min before being exposed to film.
4.4 AFM experiments
For all AFM studies, data was gathered on a Nanoscope V with Multimode 8 AFM (Bruker 
AXS, Santa Barbara, CA). The spring constant of each cantilever was calibrated prior to 
each experimental run according to the vendor’s instructions. The cantilever deflection-
sensitivity was calculated from a force curve generated by pressing the tip against the gold 
substrate in either air or PBS solution. Once sensitivity was determined, the thermal tune 
method was used to calculate the cantilever spring constant. For this method, the tip 
retracted from the substrate surface and oscillated to identify the correct resonance 
frequency.
For imaging experiments, discs of mica were glued to steel discs with epoxy and allowed to 
dry overnight. The dried mica disks were cleaved with Scotch tape to expose a fresh surface. 
10 µL of perlecan samples (10 µg/mL) were left on mica for 5 min, washed with double 
distilled water and then dried with nitrogen air. Imaging was carried out in ScanAsyst mode 
at room temperature using ScanAsyst-Air tips (spring constant: 0.4 N/m and radius: 2 nm, 
Bruker AXS). A total of 27 AFM images of full-length perlecan were traced using ImageJ 
(National Institutes of Health, Bethesda, MD) [59] and Engauge digitizer software (Free 
Software Foundation). A program written in MATLAB (The MathWorks, Natick, MA) was 
used to interpolate the xy coordinates of the perlecan contours and calculate the persistence 
length (Lp) of perlecan using a tangent to tangent correlation function [60],
(Eq. 1)
The Lp is a measure of bending stiffness of a polymer or linear molecule, with a high Lp 
conferring low flexibility. Lp is defined as the distance over which the correlation of 
tangents is lost, among two points along the contour trace. The angle, θ is that between two 
tangent vectors at a pair of points separated by a given length (L).
Pulling experiments were performed in solution under contact mode using a calibrated 
MLCT-D tips (spring constant: 0.01 N/m and radius: 20 nm, Bruker AXS). MLCT probes 
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have an intentionally dull tip ideal for force measurements and imaging extremely delicate 
samples in fluid. Perlecan at 20 nM in PBS was incubated at 37°C prior to being deposited 
onto a fresh gold substrate at room temperature for 10–15 min. The AFM tip was brought in 
contact with the surface for 1–3 s to allow the perlecan molecule to attach to the silicon 
nitride cantilever tip. All of the force measurements were obtained in aqueous PBS (pH 7.4) 
with a pulling velocity of 1000 nm/s. Aggregation of perlecan molecules was minimized by 
using a low protein sample concentration as previously described [43]. At this diluted 
concentration (one perlecan molecule per 0.8 µm3), the fluid volume displaced by the tip 
(radius of 20 nm) moving 10–100 µm into the fluid was anticipated to be approximately 
0.01–0.1 µm3. Thus, it was unlikely to have multiple perlecan molecules attached to the tip 
and the recorded forces were most likely due to single molecule engagements.
For module unfolding experiments, 1 µL of 10 mM of dithiothreitol (DTT) was added to 10 
µL of perlecan solution and incubated as described above, and force measurements were 
taken in 1 mM of PBS and DTT buffer solution. Each experiment lasted from 1–3 h.
To obtain successful tip-sample engagement, for each experimental condition roughly 500–
3000 force measurements were performed. In total, 54 native full-length, 57 GAG digested, 
and 345 DTT treated perlecan force curves were collected for data analysis. Pulling events 
capturing multiple tip interactions or oligomers were excluded from data analysis by 
selecting curves with only one detachment peak and of extension length similar to a single 
perlecan monomer. The force curves were fitted with either the extensible WLC (eWLC) 
model [61,62] (for native perlecan with or without GAG),
(2)
or inextensible WLC model [61,63–65] (for denatured DTT treated perlecan),
(3)
where x is the extension, F is the force, K is the elastic stretch modulus and β = 1/ kBT where 
kB is the Boltzmann constant, T is the temperature, Lc is the contour length of the total end-
to-end length of an extended molecule and Lp is the persistence length. Histograms of the Lc 
and Lp distributions were fitted to a Gaussian curve to get statistical measures of the two 
parameters. For unfolding studies, peak-to-peak distance was measured as change in contour 
length (ΔLc), which reflects the size of a particular region of the protein core that is 
unfolding. Equation 2 (eWLC) was used to model conditions where the protein remain 
folded, whereas, the inextensible WLC model (Eq. 3) is more suitable for protein unfolding 
and therefore used for denatured conditions.
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Highlights
• Perlecan is large enough to span the pericellular fluid annulus in cortical bone
• Perlecan withstands forces higher than expected in physiological conditions
• Perlecan functions as a flexible-rod like tether
• Disulfide linkages stabilize the domain structure of perlecan and prevent 
unfolding
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Figure 1. Schematic representation of the domain organization of human perlecan
Five structural domains are depicted as a strand of individually folded modules that share 
homology to various protein families. The entire molecule is 4391 amino acids with a core 
molecular mass approximately 470 kDa. The core protein, excluding the GAG side chains, 
is predicted to span 100–200 nm in length. With the addition of GAG chains (each 10–100 
kDa or 20–150 nm) in domains I and V the molecule’s dimensions can be extended.
Wijeratne et al. Page 16
Matrix Biol. Author manuscript; available in PMC 2017 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 2. Three-dimensional AFM images of single perlecan molecules
(A) Lane 1 is a Coomassie stain and lane 2 is a perlecan western blot (Dm IV antibody 
3135) of purified perlecan. (B) Single molecules exhibited a beads-on-a-string appearance 
with an extended linear- shaped conformation. Globular features were observed, possibly 
corresponding to protein modules. Perlecan molecules were measured to have diameters of 
2–4 nm and heights of 5–10 nm.
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Figure 3. Analysis of the contour and persistent lengths of perlecan
(A) A representative AFM image of full-length perlecan used in the analysis (total 27 
images). (B) An enlarged zoom-in image of the box in (A), showing the digitized contour 
tracing of the molecule used to find the contour length, Lc (C). Histogram showing the 
distribution of the Lc is fitted to a Gaussian curve (solid line); and the peak of the Gaussian 
is 170 nm with a standard deviation of 20 nm. (D) Cross-correlation function 〈cos(θ)〉 as a 
function of contour separation. The data were fitted to Eq. 1 to obtain persistence length Lp 
= 19 nm (as the 〈cos(θ)〉 = e−1/2 = 0.6).
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Figure 4. Stretching native full-length perlecan
(A) Purified perlecan was adsorbed onto a gold substrate and brought into contact with an 
AFM tip. As the stage moved away from the tip the perlecan molecule was pulled while 
force was recorded. (B) Two representative force-extension curves of pulling events of 
native perlecan and the GAG digested form with eWLC fitting in solid lines. The measured 
extension values in the force-extension curves ranged from 40–445 nm for native perlecan 
and 23–279 nm for the perlecan core. For both native perlecan and the GAG digested form 
there was only one peak observed. No unfolding occurred in either case.
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Figure 5. Elasticity of full-length perlecan with and without its GAG side chains
Histograms showing (A) native perlecan having a Lp of 1.2 nm and (B) a K of 2000 pN from 
fitting to a Gaussian distribution. Digesting away the GAG chains increased perlecan’s Lp to 
22 nm (C) and decreased K value (890 pN) (D).
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Figure 6. Perlecan was unfold only after being pretreated with a denaturing agent
(A) In the presence of DTT, multiple unfolding peaks were observed. Large initial peaks are 
due to non-specific attraction forces that cause tip to snap-in to the surface and therefore are 
excluded from data analysis. These peaks were fitted to the inextensible WLC model 
(dashed lines) to obtain the unfolding force. Note that the last peaks were usually as high as 
500 pN. (B) The histogram of the unfolding force, fitted with a Gaussian distribution (solid 
line), shows a peak at 110 pN. (C) The histogram of the change in contour length between 
the unfolded peaks, ΔLc, shows a peak at 35 nm.
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Figure 7. Perlecan tether under tension caused by fluid flow in the bone LCS
(A) A TEM image showing the transverse tethers span the space (~100 nm) between cell 
process membrane and canalicular wall. (B) The fluid drag force (Fd = ~1 pN) along the 
axial direction induces a tension (T = ~10 pN) within the tethering fiber, assuming the tether 
anchors at a small angle (θ = 2.87°) as suggested in (A). The projection of the tension forces 
balances with the drag force (2T sin(θ) = Fd). The tension in the tether depends on the fluid 
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drag force and the anchoring angle. Larger angles are anticipated to be associated with 
smaller tension forces under a given fluid drag force.
Wijeratne et al. Page 23
Matrix Biol. Author manuscript; available in PMC 2017 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
